We are Sorry, This Page doesn't Exist
Thermo Fisher to buy Dutch company in $11.5B deal
The most valuable company headquartered in Massachusetts, Thermo Fisher Scientific Inc., plans to get even larger through the acquisition of a Dutch maker of molecular diagnostics in a deal worth $11.5 billion. Waltham-based Thermo Fisher (NYSE: TMO) sai.....»»
GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results
CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ende.....»»
Co-Diagnostics stock soars 57% on high hopes for its coronavirus test
Shares of Co-Diagnostics Inc. , a molecular diagnostics company that.....»»
Hedge Fund and Insider Trading News: Paul Singer, Stephen Mandel, Meritage Homes Corp (MTH), Alta Equipment Group Inc (ALTG), and More
UPDATE 2-Activist Hedge Fund Elliott Builds Stake in Dutch Insurer NN Group (Reuters) AMSTERDAM, Feb 20 (Reuters) – Elliott Investment .....»»
Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports
A nearly weeklong rally for vaccine and diagnostics developers looking to capitalize on the coronavirus outbreak ended on Tuesday......»»
Co-Diagnostics" stock tumbles after stock sale agreement priced at 29% discount
Shares of Co-Diagnostics Inc. tumbled 16% in premarket trading Friday, after the molecular diagnostics company took advantage of the prior session's big .....»»
Co-Diagnostics Rallies On Plans To Develop Screening Test For Coronavirus
Shares of molecular diagnostic company Co-Diagnostics Inc (NASDAQ: CODX) are riding high on the Wuhan coronavirus wave, at their highest level in about a year. 0 read more.....»»
World"s largest asset manager gets tough on climate change
BLACKROCK-FINK/ (UPDATE 4, PIX):UPDATE 4-BlackRock takes tougher stance on climate after activist heat.....»»
Myriad Genetics"s stock surges after FDA approval of diagnostic test for pancreatic cancer
Share of Myriad Genetics Inc. shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to iden.....»»
$50M deal could expand NanoString Technologies diagnostic test into more markets
NanoString, which creates devices for molecular diagnostics and research tools to understand diseases and develop drugs, will record more than $100 million in revenue this year......»»
Sense Biodetection Raises $15.8m to Develop Diagnostics Tests
Cambridge, UK-based Sense Biodetection—or Sense—has raised a $15.8 million Series A funding round, as it scales out its portfolio of molecular diagnostics products. The round, led .....»»
OpGen To Merge With German Molecular Diagnostics Company Curetis In $24M Deal
In a health care deal announced Wednesday, OpGen Inc (NASDAQ: OPGN) said it will acquire German molecular diagnostics company Curetis. read more.....»»
Diagnostics Startup Atonarp Wins $33m Series C Round
Tokyo-based Atonarp, a high-molecular diagnostics firm, has raised $33 milli.....»»
MDxHealth (R): MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test
IRVINE, CA – August 26, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced tha.....»»
Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 2019
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with .....»»
Exact Sciences to combine with Genomic Health in cash and stock deal valued at $2.8 billion
Molecular diagnostics company Exact Sciences Corp. and Genomic Health Inc......»»
What Caused The Opening Gap In Co-Diagnostics?
For real-time updates on CODX, beat the news and login or try Benzinga Pro. Provider of molecular tools for detection of infectious diseases, Co-Diagnostics (NYSE: CODX) today had a large opening gap of 52.39%. read more.....»»
Mid-Afternoon Market Update: EXFO Falls On Downbeat Q3 Results; Co-Diagnostics Shares Surge
Toward the end of trading Thursday, the Dow traded up 0.51% to 26,996.63 while the NASDAQ fell 0.24% to 8,183.09. The S&P also fell, dropping 0.06% to 2,991.27. Leading and Lagging Sectors read more.....»»
Interpace Diagnostics" molecular thyroid cancer tests covered by Independence
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cancer Diagnostic Company Biocept"s Stock Doubles In Value: What You Need To Know
Shares of Biocept Inc (NASDAQ: BIOC), a molecular diagnostics company specializing in biomarker analysis of circulating tumor-associated DNA, are making a strong read more.....»»